|

AI for Onsite Cytology Evaluation in Endoscopic Ultrasound

RECRUITINGSponsored by Orlando Health, Inc.
Actively Recruiting
SponsorOrlando Health, Inc.
Started2025-11-12
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07228689

Summary

The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 18 years old or greater
* Patients undergoing EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract

Exclusion Criteria:

* Age less than 18 years
* Patients not undergoing sampling of solid mass lesions at EUS
* Patients with cystic lesions in the gastrointestinal tract

Conditions3

CancerGastrointestinal NeoplasmMass Lesion

Locations1 site

Orlando Health Digestive Health Institute
Orlando, Florida, 32806
Barbara J Broome321-842-6416Barbara.Broome@orlandohealth.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.